Skin & hair

The Strong Creams That Reach Thick Hand Skin

Save

The hands and feet are covered in the thickest skin on the body, which is exactly why dyshidrotic eczema resists the moderate-strength creams that calm eczema everywhere else. This walks through why potency matters here, how a high-potency course is typically structured, what occlusion does, and the point at which creams alone stop being enough.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why dyshidrotic eczema needs a stronger cream to begin with

Dyshidrotic eczema, sometimes called pompholyx, is a distinct pattern of hand and foot eczema — small, deep, intensely itchy blisters along the fingers, palms, and soles — separate from the atopic dermatitis most people picture when they hear the word eczema 1. What it shares with other eczemas is that topical corticosteroids are the mainstay of treatment; what sets it apart is where it lives.

The palms and soles carry the thickest stratum corneum on the body, and a cream that calms eczema on the arm or neck often cannot penetrate deeply enough there to do the same job. That mismatch between ordinary cream strength and unusually thick skin is the entire reason high-potency steroids come up specifically for this condition rather than as a default first choice. Many people notice flares clustering around heavy sweating, stress, or contact with nickel-containing metal, though triggers vary from person to person and are not the same for everyone.

How a high-potency course is usually structured

Topical corticosteroids are grouped into potency classes, from mild formulations suited to the face and skin folds up through high- and superhigh-potency preparations reserved for thicker or more resistant skin, and guideline-based topical steps for eczema place corticosteroids at the center of first-line treatment 2. For dyshidrotic eczema specifically, a clinician typically starts at a high-potency tier rather than working up gradually from a mild one, precisely because the palms and soles would barely respond to anything lower.

A short, clearly bounded course — applied once or twice daily for a defined number of weeks — is the usual structure for a flare, rather than an open-ended prescription meant to continue indefinitely. The blisters and itching typically start improving within days, though full flattening of thickened, chronically affected skin takes longer than the itching does to settle.

What occlusion does, and why it helps here specifically

Occlusion — covering the treated area with plastic wrap, a glove, or a sock overnight after applying the cream — meaningfully increases how much medication reaches inflamed tissue, and it is one of the more effective adjustments available for palms and soles specifically because the barrier there is so thick. A period of occlusion at night, with the area left uncovered during the day, is a common pattern for a stubborn flare.

Soaking the hands or feet in cool water for several minutes immediately before applying the steroid, then patting the skin just short of fully dry, also improves how well the medication is absorbed — a small sequencing detail that meaningfully changes how a high-potency cream performs on this particular skin.

The tradeoff: side effects of prolonged high-potency use

Extended use of a high-potency steroid carries real risks even on thick palm and sole skin, including thinning, easy bruising, stretch marks, and visible blood vessels, which is why these courses are structured with a clear endpoint rather than continued indefinitely. Prolonged use around the more delicate skin at the wrist or the sides of fingers deserves particular attention, since it thins faster than the palm itself.

These side effects are tied to duration and area, not a single application, and they are the reason a course has a stop date rather than a reason to avoid treatment altogether. A dermatologist typically plans a taper or a switch to a lower-potency maintenance option once the acute flare has settled, rather than stopping abruptly or continuing at full strength indefinitely.

Ruling out a fungal infection before treating harder

A rash on the hands or feet that looks like dyshidrotic eczema can also be a fungal infection, and the two are treated in opposite directions — a fungal process usually stays the same or worsens under a steroid, since steroids suppress the immune response that would otherwise fight it back. A dyshidrotic vs fungal distinction often comes down to a simple scraping test a clinician can perform in the office when the diagnosis is not obvious from appearance alone.

Getting this differentiation wrong before applying a strong steroid is the most common reason a "resistant" case turns out not to be resistant at all — it was never dyshidrotic eczema to begin with, or a fungal infection developed on top of it partway through treatment.

When hand eczema has outrun the cream

When blisters keep recurring despite a properly structured high-potency course, or cover a large enough area of the hands and feet to make daily cream application impractical, hand eczema has outrun the cream and the next step usually moves beyond topical treatment. Guidelines for related eczematous disease describe light therapy for hand eczema and systemic options — including biologics and JAK inhibitor pills — for disease that has not responded adequately to topical therapy 3.

That escalation is a dermatologist's call, made after confirming the diagnosis and documenting that an adequate topical course was actually tried, not a step to reach for the first time a flare feels frustrating.

Keeping the skin barrier intact between flares

Between flares, the goal shifts from treating active blisters to keeping the skin barrier intact enough that the next flare is milder and further apart. A thick barrier cream hand eczema routine — applied after every hand wash, not just at bedtime — replaces the lipids that frequent washing strips away, and a potassium permanganate soak is sometimes used for weeping or partly infected blisters before a moisturizer or steroid is applied.

For the thinner skin at the finger webs and sides, where high-potency steroids carry more risk of thinning with repeated use, calcineurin inhibitors for eczema such as tacrolimus offer a steroid-free option for maintenance between flares, trading some potency for a treatment that can be used for longer stretches without the same skin-thinning risk.

Common questions

The palms and soles have the thickest skin on the body, so a moderate-strength cream that works well on the arms or neck often cannot penetrate deeply enough to reach the inflammation causing the blisters. A high-potency steroid is chosen specifically to overcome that barrier, not because dyshidrotic eczema is inherently more severe than other forms.

Courses are typically structured for a defined number of weeks rather than left open-ended, since prolonged high-potency use carries its own risks. Blisters and itching often improve within days, but a dermatologist usually plans a taper or a switch to a gentler option once the flare has settled rather than stopping abruptly.

Occlusion with plastic wrap, a glove, or a sock increases how much medication reaches the skin and is a standard technique for stubborn hand and foot flares, typically used overnight for a limited stretch of a flare. It is meant to be time-limited and directed by a clinician, not an ongoing nightly habit.

Yes, and the distinction matters because a fungal infection usually worsens under a steroid rather than improving. A simple skin scraping examined in the office can settle the question when blisters do not respond the way expected, before a stronger or longer steroid course is tried.

Recurring blisters despite a properly structured high-potency course, or blisters covering a large area, are the signal to move beyond topical treatment. A dermatologist can confirm the diagnosis and consider light therapy or a systemic medication rather than repeating the same cream indefinitely.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When dyshidrotic eczema needs more than a steroid cream

  • —Blisters that spread rapidly, weep pus, or develop increasing redness and warmth, which can signal a secondary bacterial infection
  • —Fever or swollen lymph nodes near the hands or feet along with a worsening rash
  • —No improvement after a full course of high-potency steroid used as directed
  • —Skin thinning, persistent redness, or visible small blood vessels developing where the steroid has been applied

Blisters with spreading redness, warmth, and fever point toward a secondary infection and warrant same-day urgent care or an emergency department rather than continuing the steroid alone.

This article is general education, not a diagnosis or a treatment plan. Whether high-potency steroids are the right choice, and for how long, depends on an in-person evaluation by a clinician who can confirm the diagnosis.

References

  1. 1.National Institute of Arthritis and Musculoskeletal and Skin Diseases (2024). Atopic Dermatitis (Eczema). NIH / NIAMS. link ✓Definitional overview of atopic dermatitis as a distinct chronic inflammatory itchy skin condition, used here to distinguish it from dyshidrotic eczema, a separate hand-and-foot pattern that can occur independently of atopic dermatitis.
  2. 2.Sidbury R, Alikhan A, Bercovitch L, et al. (2023). Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2022.12.029Guideline placing topical corticosteroids at the center of first-line topical treatment for eczema, supporting the potency-tiered approach to topical treatment applied here to dyshidrotic eczema.
  3. 3.Sidbury R, Davis DM, Alikhan A, et al. (2024). Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. PMID 37943240Guideline describing phototherapy and systemic therapy, including biologics and JAK inhibitors, as the escalation tier for eczema that has not responded adequately to topical treatment.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library